Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

Xiamen Amoytop Biotech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	4,022	3,696	2,817	2,100	1,527	1,132
Revenue Growth	28.16%	31.18%	34.13%	37.55%	34.86%	42.61%
Gross Profit Gross Profit Growth	3,665	3,436	2,634	1,960	1,356	1,005
Operating Income Operating Income Growth	1,296	1,214	930.33	659.88	360.06	221.64
Net Income Net Income Growth	1,080	1,031	827.6	555.45	287.02	181.2
Earnings Per Share EPS Growth	2.63	2.52	2.03	1.37	0.71	0.45
EPS Growth	12.89%	24.14%	48.18%	92.96%	57.78%	55.17%

Revenue by Geography

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
East China East China Growth	1,343
Central China Central China Growth	500.97
Southwest China Southwest China Growth	678.1
South China South China Growth	331.89
Northeast China Northeast China Growth	124.23
North China North China Growth	440.34
Northwest China Northwest China Growth	254.17
Overseas Overseas Growth	8.09
Total Total Growth	3,680

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	947.98	1,016	661.79	670.04	572.02	481.8
Total Debt Total Debt Growth	769.53	175.97	8.94	7.92	9.74	25.16
Net Cash (Debt) Net Cash Growth	178.45	839.67	652.85	662.11	562.28	456.63
Net Cash Growth	-72.56%	28.62%	-1.40%	17.76%	23.14%	2.28%
Net Cash Per Share Net Cash Per Share Growth	0.43	2.05	1.60	1.63	1.39	1.13

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	705.37	729.38	430.63	512.1	363.16	234.78
Capital Expenditures CapEx Growth	-302.34	-256.14	-251.35	-288.46	-219.17	-190.93
Free Cash Flow Free Cash Flow Growth	403.04	473.23	179.28	223.64	143.99	43.85
Free Cash Flow Growth	-19.29%	163.96%	-19.84%	55.31%	228.34%	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	91.14%	92.97%	93.49%	93.33%	88.80%	88.78%
Operating Margin	32.23%	32.84%	33.02%	31.42%	23.58%	19.57%
Pretax Margin	30.55%	31.80%	33.05%	30.50%	23.31%	19.01%
Profit Margin	26.85%	27.91%	29.38%	26.45%	18.80%	16.00%
FCF Margin	10.02%	12.80%	6.36%	10.65%	9.43%	3.87%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.620	0.620	0.620	0.410	0.213	0.100
Dividend Per Share Growth	0%	0%	51.22%	92.49%	113.00%	100.00%
Dividend Yield	1.03%	0.75%	0.86%	0.80%	0.56%	0.35%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	23.54	33.12	36.06	38.34	55.18	65.73
Forward PE	18.24	25.11	29.30	33.50	28.12	28.12
P/FCF Ratio	62.67	72.18	166.48	95.23	109.98	271.61
PS Ratio	6.28	9.24	10.60	10.14	10.37	10.52

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error